Brain stimulation for depression and chronic pain | Sooma tDCS™ - Sooma
Overview
Sooma Medical is a company specializing in neurotechnology, headquartered in Helsinki, Uusimaa. The company develops, manufactures, and markets non-invasive therapy devices for neurological and psychiatric disorders, specifically targeting depression and chronic pain. Sooma utilizes transcranial direct current stimulation (tDCS) technology, which is trusted by over 150 clinics worldwide. The company's first product is a portable device approved for the treatment of major depressive disorder (MDD), which is CE-approved and marketed in the EU and other regions. Additionally, Sooma's quality management system has received ISO 13485:2016 and MDSAP certifications, ensuring high standards in their operations.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Helsinki, Uusimaa
- Type
- Privately Held
- Founded
- 2013
- Followers
- 3,393
- Specialties
- Medical devices, Neuromodulation, Neurological devices, Therapeutics, psychiatry, tDCS, depression, mentalhealth, neurotech, and digital health
- Locations
- Atomitie 5 C Helsinki, Uusimaa 00370, FI
Funding
Total rounds: 7
Last round: Seed, Apr 12, 2024
Last round amount: US$ 5.5M